SHATTUCK LABS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.9 USD | +4.32% |
|
-1.20% | +38.85% |
| Mar. 04 | Shattuck Labs, Inc. Announces Board Appointments | CI |
| Mar. 01 | Sector Update: Health Care Stocks Rising Late Afternoon | MT |
Chart calendar Shattuck Labs, Inc.
ac1c5.hH7lwqwrbvP9A1kpQcXuu432cvoKhAHra1svBzNa_aU.xSugjPQdL5Cod2EeJ_yrw9mMKJV_7nOMXwRgYHALjen2CsiP3E8GmJJKDA~4068c5481a4c2626c487405204ed733a
Upcoming events on Shattuck Labs, Inc.
Past events on Shattuck Labs, Inc.
| 2024-04-17 12:00 pm | Citi Biotech C-Suite Conference |
| 2024-04-09 07:05 pm | American Association for Cancer Research Meeting - Abstract Number: 6584 |
| 2024-04-08 01:30 pm | Needham Healthcare Conference |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-11 03:00 pm | J.P. Morgan Healthcare Conference |
| 2023-12-13 08:00 am | Business Update Call |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract (#4278) |
| 2023-11-29 09:10 am | Evercore ISI HealthCONx Conference |
| 2023-11-09 08:00 am | Q3 2023 Earnings Call |
| 2023-11-09 06:00 am | Q3 2023 Earnings Release |
| 2023-08-10 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-05 02:15 pm | American Society of Clinical Oncology Conference - Poster No - #239 |
| 2023-05-23 11:00 am | Annual General Meeting |
| 2023-05-09 04:00 pm | Q1 2023 Earnings Release |
| 2023-04-19 02:15 pm | Needham Healthcare Conference - Fireside Chat |
| 2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No 1815 |
| 2023-04-13 | American Association for Cancer Research Meeting |
| 2023-03-13 02:00 pm | Oppenheimer Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,89 | 9,93 10,00 -0.62% | 30,0 2,26 1226.43% | 0,65 0,25 163.25% | 1,66 1,14 45.71% | 0,81 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -43,9 -73,0 39.88% | -100 -102 1.33% | -87,9 -95,4 7.81% | -84,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -36,9 -40,3 8.38% | -45,3 -73,6 38.46% | -103 -104 0.27% | -92,0 -99,2 7.26% | -90,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -45,0 -73,0 38.39% | -102 -103 0.81% | -87,3 -95,2 8.26% | -91,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -45,0 -73,0 38.39% | -102 -103 0.96% | -87,3 -94,9 8.05% | -91,6 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -1,07 -1,73 38.15% | -2,41 -2,42 0.41% | -2,05 -2,20 6.71% | -1,75 |
| Announcement Date | 18/09/20 | 15/03/21 | 15/03/22 | 23/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 30,1 1,98 1422.94% | 0,00 0,38 - | 0,05 0,00 - | 0,21 0,00 - | 0,39 0,02 1633.33% | 0,06 0,09 -32.94% | 0,20 0,09 122.22% | 0,69 0,17 294.25% | 0,71 0,20 253.47% | 0,18 | 0,20 | 0,20 | 0,22 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -23,7 -21,9 -8.19% | -26,5 -24,6 -7.82% | -24,3 -28,7 15.35% | -25,3 -27,6 8.44% | -20,6 -27,4 24.65% | -20,3 -22,6 10.09% | -27,6 -23,5 -17.35% | -18,0 -23,9 24.78% | -19,9 | -20,6 | -21,6 | -22,7 | ||
|
EBIT Million USD | Released Forecast Spread | 9,25 -18,3 150.59% | -24,2 -21,9 -10.35% | -27,7 -25,3 -9.46% | -25,2 -28,5 11.32% | -26,3 -27,0 2.82% | -21,7 -25,8 15.88% | -22,7 -21,9 -3.71% | -28,6 -22,0 -30.14% | -19,0 -26,7 29.05% | -21,0 | -21,0 | -21,9 | -22,0 | -19,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -24,6 0.29% | -27,4 -25,2 -8.51% | -24,6 -28,4 13.24% | -25,4 -27,0 5.72% | -20,7 -26,0 20.39% | -21,3 -22,1 3.31% | -27,5 -21,7 -26.67% | -17,7 -25,6 30.99% | -21,1 | -21,5 | -22,9 | -23,6 | -19,8 | |
|
Net income Million USD | Released Forecast Spread | -24,5 -24,6 0.29% | -27,4 -25,2 -8.51% | -24,6 -28,4 13.24% | -25,4 -27,0 5.72% | -20,7 -26,0 20.39% | -21,3 -22,1 3.31% | -27,5 -21,7 -26.67% | -17,7 -25,6 30.99% | -21,1 | -21,5 | -22,9 | -23,6 | -19,8 | |
|
EPS USD | Released Forecast Spread | -0,58 -0,58 0% | -0,65 -0,59 -9.55% | -0,58 -0,67 13.43% | -0,60 -0,63 5.14% | -0,49 -0,63 21.6% | -0,50 -0,52 2.91% | -0,65 -0,51 -26.95% | -0,41 -0,57 27.43% | -0,46 | -0,44 | -0,43 | -0,43 | -0,42 | |
| Announcement Date | 15/03/22 | 12/05/22 | 11/08/22 | 08/11/22 | 23/02/23 | 09/05/23 | 10/08/23 | 09/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Shattuck Labs, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STTK Stock
- Calendar Shattuck Labs, Inc.
